ReoPro, Eli Lilly: Malaysia
solution for injection 2 mg/ml
(vials 5 ml and 20 ml)
platelet aggregation inhibitor
Indications: Coronary angioplasty.
Simulect, Novartis: Switzerland
solution for injection 20 mg/5ml vial
platelet aggregation inhibitor
Indications: Kidney transplant rejection.
Sympal; Enantyum: Menarini: Germany
coated tablets 12.5, 25 mg
nonsteroidal anti-inflammatory agent
Indications: Symptomatic treatment of moderate to severe pain.
Aricept, Pfizer: Iceland
coated tablets 5 mg, 10 mg
Indications: Symptomatic treatment of mild to moderate Alzheimer’s disease.
Feridex, Ferumoxides: Eiken: Japan
intravenous injection 56 mg Fe/ampoule
diagnostic aid; contrast medium
Indications: Diagnosis of location of hepatic tumors in magnetic resonance imagining computed tomography.
Telfast, Hoechst Merrell Dow: Spain
tablet 180 mg
histamine H1-antagonist (metabolite of terfenadine)
Indication: Relief of symptoms associated with seasonal allergic rhinitis in adults.
Bisphonal, Yamanouchi: Japan
solution for intravenous infusion 10 mg/ampoule
Indications: Hypercalcaemia due to malignant tumours.
Contraindications: Patients with a history of hypersensitivity to this product or other biphosphonates. Safety in pregnant women, infants and children has not been established.
Precautions: The usefulness of this product in the treatment of hypercalcaemia due to reasons other than malignant tumours (such as parathyroidal hyperactivity) has not been established. To be used with caution in patients with serious renal disorders, patients with cardiac disease, debilitated patients, and the elderly. Renal function tests should be performed after administration.
Adverse reactions: Fever, hypotension, disturbed consciousness; renal effects (raised levels of urinary protein, sugar, bilirubin, increased sediment); hepatic effects (raised serum transaminases and LDH); haematological effects (leukocytosis, neutrophilia, eosinopenia, lymphopenia).
Campto, Rhone-Poulenc Rorer: Switzerland
infusion concentrate 40 mg/2 ml vial;
100 mg/5 ml vial
Indications: [Not stated].
Lacidipine BI Pharma, Boehringer-Ingelheim: Germany
tablet 2, 4 mg
calcium channel blocker
Indications: Essential hypertension.
Liserdol, Kohl Pharma: Germany
coated tablet 4 mg
Indications: Suppression of lactation; galactorrhoea, prolactin-dependent amenorrhoea; prolactin-dependent infertility in women; disturbances of fertility, diminished libido and impotence in men.
Modiodal, Lab. L. Lafon: Germany
tablets 100 mg
Indications: Narcolepsy with or without cataplexy.
Viracept, Roche: Spain, UK
tablet 250 mg
HIV protease inhibitor; antiretroviral agent
Indications: Treatment of HIV-1 infected patients with advanced or progressive immunodeficiency, in combination with antiretroviral nucleoside analogues.
Viramune, Boehringer Ingelheim: EC, Spain, UK
tablet 200 mg
HIV-1 non-nucleoside reverse transcriptase inhibitor; antiretroviral agent
Indications: Patients with advanced or progressive HIV infection as part of combination therapy with nucleoside analogues.
*pentazocine + naloxone
Pentagin: Sankyo: Japan
tablet 25 mg + 250 micrograms
narcotic analgesic + morphine antagonist
Indications: Relief of pain in various types of cancer.
Contraindications: Patients who are hypersensitive to pentazocine or naloxone, patients with head injuries or intracranial hypertension, severe respiratory depression or severely impaired health. Precautions: Patients with a history of drug dependence, biliary tract disease, myocardial infarction, hepatic dysfunction and elderly patients. Patients shouldnot operate machinery or drive during treatment.
Adverse reactions: Shock, respiratory depression.
Mylis, Kanebo: Japan
vaginal suppository 600 mg
Indications: Promotion of cervical ripening insufficiency in the third trimester of pregnancy.
Seroquel, Zeneca: Bahrain, Iceland
tablets 25 mg, 100 mg, 200 mg
neuroleptic benzodiazepine derivative with antipsychotic effect
Indications: Treatment of schizophrenia.
Norvir: Abbott: Japan
capsule 100 mg
Indications: In combination with nucleoside analogue reverse transcriptase inhibitors for the treatment of AIDS and symptomatic and asymptomatic HIV infection with pre-treatment CD4 lymphocyte count of 500/mm3 or less.
Viagra, Pfizer: EC, Switzerland
tablets 25 mg, 50 mg, 100 mg
cGMP-specific phosphodiesterase type 5
Indication: Erectile dysfunction.
Contraindications: Known history of hypersensitivity to any component of the product. Concurrent administration to patients using organic nitrates in any form.
Precautions: Patients should undergo a thorough cardiovascular examination before starting treatment. Adverse reactions: Headache, flushing, abnormal vision.
Note: First approved in the USA - see Pharmaceuticals Newsletter Nos. 5&6, May & June 1998.
Zerit, Bristol-Myers Squibb: Japan
capsules 15 mg, 20 mg
Indications: AIDS; symptomatic or asymptomatic treatment of HIV infection with CD4 count of 500/mm3 or less before treatment. Note: Not to be used as monotherapy as a first-line therapy.
tetracycline and metronidazole and bismuth subcitrate
Panmycin, Trichozole, De-Nol: Pharmacia & Upjohn: New Zealand
tetracycline: capsule 250 mg
metronidazole: tablet 400 mg
bismuth subcitrate: 120 mg
(triple therapy pack)
antibiotic + antiprotozoal agent + bismuth salt
Indications: Triple therapy for the eradication of Helicobacter pylori (tetracycline four times a day, metronidazole three times a day and bismuth subcitrate four times a day, for 14 days).
Navoban, Novartis: Japan
capsule 5 mg
serotonin receptor antagonist; antiemetic
Indications: Cancer-chemotherapy induced gastrointestinal symptoms including nausea and vomiting (e.g. cisplatin).